HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Beaucell launches stem-cell skin care

This article was originally published in The Rose Sheet

Executive Summary

Korea-based firm FCB-Pharmicell introduces Anti-Aging Regeneration Daily Program to "inspire vitality and clearness to your damaged and exhausted skin," at HBA Global Expo. Program includes a toner which "refines surface texture" and an emulsion "leaving the surface fully moist and elastic." Each contains 0.5% adult stem-cell extract. In addition, an anti-wrinkle eye cream contains yeast proteins and grain peptide to "provide elasticity and bright clearness," a cream with hexa-peptides for "flexibility" and an essence gel "for nourishment and moisture," all containing 7% adult stem-cell extract. Firm has studied anti-aging effects of stem cell media and currently has three products in IND-Phases 2 and 3 targeting acute ischemic stroke, acute myocardial infarction and spinal cord injury. Beaucell's five-product kit retails for $800 in spas

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017267

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel